Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-02-02

FDA Approved: CYCLOSPORINE — Original Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved Mylan Pharmaceuticals' original application for cyclosporine, a generic immunosuppressant product. This makes a generic cyclosporine available …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYCLOSPORINE (cyclosporine)

Snippet

ORIG AP for CYCLOSPORINE (CYCLOSPORINE)